Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RARB | P10826 | 6/20 | 0.54 |
| ▸ | HSD11B1 | P28845 | 2/20 | 0.54 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.47 |
| ▸ | MEN1 | O00255 | 1/20 | 0.47 |
| ▸ | RARA | P10276 | 1/20 | 0.47 |
| ▸ | MAPT | P10636 | 1/20 | 0.47 |
| ▸ | MTOR | P42345 | 1/20 | 0.47 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.47 |
| ▸ | KCNH2 | Q12809 | 2/20 | 0.47 |
| ▸ | CA1 | P00915 | 1/20 | 0.47 |
| ▸ | CA2 | P00918 | 1/20 | 0.47 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.47 |
| ▸ | HTR1A | P08908 | 1/20 | 0.47 |
| ▸ | ADRA2A | P08913 | 1/20 | 0.47 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.47 |
| ▸ | DRD1 | P21728 | 1/20 | 0.47 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.47 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.47 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.47 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL289833 | 1.00 | RARB (0.54) | RARBHSD11B1ALDH1A1MEN1RARA | |
| SCHEMBL12533891 | 1.00 | RARB (0.54) | RARBHSD11B1ALDH1A1MEN1RARA | |
| SCHEMBL38667 | 1.00 | RARB (0.54) | RARBHSD11B1ALDH1A1MEN1RARA | |
| SCHEMBL13474962 | 1.00 | RARB (0.54) | RARBHSD11B1ALDH1A1MEN1RARA | |
| SCHEMBL10042892 | 0.98 | HSD11B1 (0.57) | RARBHSD11B1ALDH1A1MEN1RARA | |
| SCHEMBL11887113 | 0.96 | HSD11B1 (0.58) | RARBHSD11B1ALDH1A1MEN1RARA | |
| SCHEMBL12386345 | 0.96 | HSD11B1 (0.58) | RARBHSD11B1ALDH1A1MEN1RARA | |
| SCHEMBL10042894 | 0.96 | HSD11B1 (0.58) | RARBHSD11B1ALDH1A1MEN1RARA | |
| SCHEMBL16234053 | 0.95 | RARB (0.50) | RARBHSD11B1ALDH1A1MEN1RARA | |
| SCHEMBL16253925 | 0.95 | RARB (0.56) | RARBHSD11B1ALDH1A1MEN1RARA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 66 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10281831-B2 | Imaging members comprising capped structured organic film compositions | XEROX CORPORATION (US) | 2019-05-07 | — | — | US | disclosed |
| US-9921500-B2 | Fluorinated structured organic film photoreceptor layers | XEROX CORPORATION (US) | 2018-03-20 | — | — | US | disclosed |
| US-20180004102-A1 | METHOD FOR MANUFACTURING FLUORINATED STRUCUTURED ORGANIC PHOTORECEPTOR LAYERS | XEROX CORPORATION | 2018-01-04 | — | — | US | disclosed |
| US-20180004103-A1 | FLUORINATED STRUCUTURED ORGANIC FILM LAYERS | XEROX CORPORATION | 2018-01-04 | — | — | US | disclosed |
| EP-3264183-A1 | FLUORINATED STRUCUTURED ORGANIC FILM LAYER PHOTORECEPTOR LAYERS | Xerox Corporation (US) | 2018-01-03 | — | — | EP | disclosed |
| EP-3264182-A1 | METHOD FOR MANUFACTURING FLUORINATED STRUCUTURED ORGANIC PHOTORECEPTOR LAYERS | Xerox Corporation (US) | 2018-01-03 | — | — | EP | disclosed |
| US-20170075238-A1 | FLUORINATED STRUCTURED ORGANIC FILM PHOTORECEPTOR LAYERS | XEROX CORPORATION (US) | 2017-03-16 | — | — | US | disclosed |
| US-9567425-B2 | Periodic structured organic films | XEROX CORPORATION (US) | 2017-02-14 | — | — | US | disclosed |
| US-20170022338-A1 | PERIODIC STRUCTURED ORGANIC FILMS | XEROX CORPORATION | 2017-01-26 | — | — | US | disclosed |
| EP-2403657-B1 | PROCESS FOR PREPARING STRUCTURED ORGANIC FILMS (SOFS) VIA A PRE-SOF | XEROX CORP (US) | 2016-12-28 | — | — | EP | disclosed |
| US-20110217642-A1 | CHARGE TRANSPORT PARTICLES | XEROX CORPORATION (US) | 2011-09-08 | — | — | US | disclosed |
| WO-2010102038-A1 | ELECTRONIC DEVICES COMPRISING STRUCTURED ORGANIC FILMS | XEROX CORPORATION (US) | 2010-09-10 | — | — | WO | disclosed |
| US-20100227157-A1 | COMPOSITE STRUCTURED ORGANIC FILMS | XEROX CORPORATION (US) | 2010-09-09 | — | — | US | disclosed |
| US-20100228025-A1 | STRUCTURED ORGANIC FILMS HAVING AN ADDED FUNCTIONALITY | XEROX CORPORATION (US) | 2010-09-09 | — | — | US | disclosed |
| US-20100227998-A1 | STRUCTURED ORGANIC FILMS | XEROX CORPORATION (US) | 2010-09-09 | — | — | US | disclosed |
| US-20100227081-A1 | MIXED SOLVENT PROCESS FOR PREPARING STRUCTURED ORGANIC FILMS | XEROX CORPORATION (US) | 2010-09-09 | — | — | US | disclosed |
| US-20100224867-A1 | ELECTRONIC DEVICES COMPRISING STRUCTURED ORGANIC FILMS | XEROX CORPORATION (US) | 2010-09-09 | — | — | US | disclosed |
| US-20100227071-A1 | PROCESS FOR PREPARING STRUCTURED ORGANIC FILMS (SOFS) VIA A PRE-SOF | XEROX CORPORATION (US) | 2010-09-09 | — | — | US | disclosed |
| US-20100221648-A1 | ZINC THIONE PHOTOCONDUCTORS | XEROX CORPORATION (US) | 2010-09-02 | — | — | US | disclosed |
| US-20100221648-A1 | ZINC THIONE PHOTOCONDUCTORS | XEROX CORPORATION (US) | 2010-09-02 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100224867-A1 | ELECTRONIC DEVICES COMPRISING STRUCTURED ORGANIC FILMS | EPCAM, EPHA6, EED | RARB 1405/4885HSD11B1 4746/4885ALDH1A1 866/4885 |
| US-20100228025-A1 | STRUCTURED ORGANIC FILMS HAVING AN ADDED FUNCTIONALITY | VIM, PUF60, EPCAM | RARB 1629/4885HSD11B1 4727/4885ALDH1A1 1258/4885 |
| US-20100227998-A1 | STRUCTURED ORGANIC FILMS | VIM, PUF60, EPCAM | RARB 1478/4885HSD11B1 4727/4885ALDH1A1 1213/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.